Mutational signatures in squamous cell carcinoma of the lung

BACKGROUND: Tumor mutational burden (TMB) has been identified as one of the predictors for the response to anti-programmed cell death-1 (anti-PD-1) antibody therapy and reported to correlate with smoking history in lung adenocarcinoma. However, in squamous cell carcinoma of the lung, the association...

Descripción completa

Detalles Bibliográficos
Autores principales: Osoegawa, Atsushi, Takada, Kazuki, Okamoto, Tatsuro, Sato, Seijiro, Nagahashi, Masayuki, Tagawa, Tetsuzo, Tsuchida, Masanori, Oki, Eiji, Okuda, Shujiro, Wakai, Toshifumi, Mori, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947495/
https://www.ncbi.nlm.nih.gov/pubmed/33717580
http://dx.doi.org/10.21037/jtd-20-2602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947495/
https://www.ncbi.nlm.nih.gov/pubmed/33717580
http://dx.doi.org/10.21037/jtd-20-2602

Ejemplares similares